WAKEFIELD, Mass., September 11, 2020 — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, announced today it received approval to build a new dispensary in Bordentown Township, New Jersey.
The new location, located at 191 Route 130 North, will be the company’s second dispensary in the state.
The New Jersey expansion allows Curaleaf to better serve the needs of the more than 80,000 patients enrolled in the states medical program. Construction on the more than 9,000 square foot facility is set to begin this fall and the site will open in early 2021. Like all Curaleaf dispensaries, the new location will provide patients with a destination for compassionate guidance, education, and will feature the company’s assortment of high-quality cannabis products and brands so patients can consume cannabis with ease, clarity, and confidence.
Curaleaf currently operates in 23 states with 92 dispensaries, 22 cultivation sites and over 30 processing sites. For details on Curaleaf’s dispensary location in New Jersey, along with hours of operation and contact information, please visit curaleaf.com/locations#new-jersey
About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is the leading vertically integrated U.S. multi-state cannabis operator with a mission to improve lives by providing clarity around cannabis and confidence around consumption.
As a high-growth cannabis company known for quality, expertise and reliability, the company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets.
Curaleaf currently operates in 23 states with 92 dispensaries, 22 cultivation sites and over 30 processing sites, and employs over 3,000 team members across the United States.
Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF.